Press releases and In the Media.

Check out the latest news articles featuring Scopio

Press Release
April 17, 2024

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more
In the Media 1 min
August 02, 2022

Beckman Coulter and Scopio Labs accelerate adoption of hematology digital cell morphology platform

Beckman Coulter and Scopio Labs have announced a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Using AI, Scopio have developed scanners which...
Link to full article
Press Release 3 mins
July 20, 2022

Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate adoption of...
Read more
In the Media 2 mins
June 20, 2022

Replacing microscopes with digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT...
Link to full article
In the Media 1 min
June 17, 2022

FDA clears Scopio Labs digital cell morphology platform

Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the Media 1 min
June 12, 2022

Scopio Labs Gets FDA Clearance For Blood Smear Device

Israeli digital microscopy company Scopio Labs, announced this week that it has received US FDA 510(k) clearance for its X100HT device with Full-Field Peripheral Blood Smear (PBS) Application to improve the...
Link to full article
In the Media 2 mins
June 10, 2022

High Throughput Hematological Analysis Platform Receives FDA Clearance

Scopio Labs announced that its X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for...
Link to full article
Press Release 4 mins
June 09, 2022

Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

This is the company's second FDA clearance, broadening its suite of fully digital platforms to cater to all lab sizes and networks. Coupling high throughput capabilities with the highest resolution for...
Read more
In the Media 3 mins
June 09, 2022

AI-powered scope developer says new FDA clearance opens the door for telehematology

Scopio Labs today announced FDA 510(k) clearance for its X100HT, which features a new slide loader that automatically prepares samples and feeds them into the digital blood scanner for AI-powered analysis. The...
Link to full article
In the Media 6 mins
May 26, 2022

Digital Microscope Streamlines The Search For Cell Abnormalities In Blood

Microscopes can see what is invisible to the naked eye. For this reason, and many others, they are essential for scientists who aim the learn more about the way the human body operates by studying those...
Link to full article